These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27566819)

  • 41. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties.
    Vigano S; Negron J; Ouyang Z; Rosenberg ES; Walker BD; Lichterfeld M; Yu XG
    J Virol; 2015 Aug; 89(15):7829-40. PubMed ID: 25995260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-Cell Subsets (T
    Meraviglia S; Di Carlo P; Pampinella D; Guadagnino G; Presti EL; Orlando V; Marchetti G; Dieli F; Sergi C
    Ann Clin Lab Sci; 2019 Sep; 49(4):519-528. PubMed ID: 31471343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection.
    Simonetta F; Hua S; Lécuroux C; Gérard S; Boufassa F; Sáez-Cirión A; Pancino G; Goujard C; Lambotte O; Venet A; Bourgeois C
    J Virol; 2014 Oct; 88(20):11861-71. PubMed ID: 25100841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.
    Hersperger AR; Pereyra F; Nason M; Demers K; Sheth P; Shin LY; Kovacs CM; Rodriguez B; Sieg SF; Teixeira-Johnson L; Gudonis D; Goepfert PA; Lederman MM; Frank I; Makedonas G; Kaul R; Walker BD; Betts MR
    PLoS Pathog; 2010 May; 6(5):e1000917. PubMed ID: 20523897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.
    Carrière M; Lacabaratz C; Kök A; Benne C; Jenabian MA; Casartelli N; Hüe S; Hocqueloux L; Lelièvre JD; Lévy Y
    J Infect Dis; 2014 May; 209(9):1321-30. PubMed ID: 24357632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Partial recovery of senescence and differentiation disturbances in CD8
    Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
    Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-Specific CD8+ T Cell-Mediated Viral Suppression Correlates With the Expression of CD57.
    Jensen SS; Tingstedt JL; Larsen TK; Brandt L; Gerstoft J; Kronborg G; Pedersen C; Fomsgaard A; Karlsson I
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):8-16. PubMed ID: 26761268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.
    Jennes W; Camara M; Dièye T; Mboup S; Kestens L
    J Virol; 2008 Sep; 82(17):8619-28. PubMed ID: 18562522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High levels of CD57+CD28- T-cells, low T-cell proliferation and preferential expansion of terminally differentiated CD4+ T-cells in HIV-elite controllers.
    Ruiz-Mateos E; Ferrando-Martinez S; Machmach K; Viciana P; Pacheco YM; Nogales N; Genebat M; Leal M
    Curr HIV Res; 2010 Sep; 8(6):471-81. PubMed ID: 20636274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.
    Sauce D; Larsen M; Fastenackels S; Pauchard M; Ait-Mohand H; Schneider L; Guihot A; Boufassa F; Zaunders J; Iguertsira M; Bailey M; Gorochov G; Duvivier C; Carcelain G; Kelleher AD; Simon A; Meyer L; Costagliola D; Deeks SG; Lambotte O; Autran B; Hunt PW; Katlama C; Appay V
    Blood; 2011 May; 117(19):5142-51. PubMed ID: 21436070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children.
    Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M
    New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD4 T-cell regeneration in HIV-1 elite controllers.
    Yang Y; Al-Mozaini M; Buzon MJ; Beamon J; Ferrando-Martinez S; Ruiz-Mateos E; Rosenberg ES; Pereyra F; Yu XG; Lichterfeld M
    AIDS; 2012 Mar; 26(6):701-6. PubMed ID: 22301416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function.
    Chevalier MF; Jülg B; Pyo A; Flanders M; Ranasinghe S; Soghoian DZ; Kwon DS; Rychert J; Lian J; Muller MI; Cutler S; McAndrew E; Jessen H; Pereyra F; Rosenberg ES; Altfeld M; Walker BD; Streeck H
    J Virol; 2011 Jan; 85(2):733-41. PubMed ID: 21047960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients.
    Pannus P; Adams P; Willems E; Heyndrickx L; Florence E; Rutsaert S; De Spiegelaere W; Vandekerckhove L; Seguin-Devaux C; Vanham G
    AIDS; 2019 Mar; 33(3):387-398. PubMed ID: 30702513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8
    Kwaa AKR; Talana CAG; Blankson JN
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential.
    Card CM; Keynan Y; Lajoie J; Bell CP; Dawood M; Becker M; Kasper K; Fowke KR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):427-37. PubMed ID: 22240463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN
    J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection.
    Leligdowicz A; Onyango C; Yindom LM; Peng Y; Cotten M; Jaye A; McMichael A; Whittle H; Dong T; Rowland-Jones S
    Eur J Immunol; 2010 Jul; 40(7):1963-72. PubMed ID: 20411566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort.
    Thiébaut R; Matheron S; Taieb A; Brun-Vezinet F; Chêne G; Autran B;
    AIDS; 2011 Mar; 25(6):865-7. PubMed ID: 21358376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV Controllers Exhibit Effective CD8
    Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD
    Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.